These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23188187)

  • 1. The increasing secondary care burden of idiopathic pulmonary fibrosis: hospital admission trends in England from 1998 to 2010.
    Navaratnam V; Fogarty AW; Glendening R; McKeever T; Hubbard RB
    Chest; 2013 Apr; 143(4):1078-1084. PubMed ID: 23188187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care burden and medical resource utilisation of idiopathic pulmonary fibrosis in Korea.
    Kim SW; Myong JP; Yoon HK; Koo JW; Kwon SS; Kim YH
    Int J Tuberc Lung Dis; 2017 Feb; 21(2):230-235. PubMed ID: 28234090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital cost and length of stay in idiopathic pulmonary fibrosis.
    Mooney JJ; Raimundo K; Chang E; Broder MS
    J Med Econ; 2017 May; 20(5):518-524. PubMed ID: 28092235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective observational study of trends in hospital admissions for idiopathic pulmonary fibrosis in Spain (2004-2013) using administrative data.
    Pedraza-Serrano F; López de Andrés A; Jiménez-García R; Jiménez-Trujillo I; Hernández-Barrera V; Sánchez-Muñoz G; Puente-Maestu L; de Miguel-Díez J
    BMJ Open; 2017 Feb; 7(2):e013156. PubMed ID: 28193850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rising incidence of idiopathic pulmonary fibrosis in the U.K.
    Navaratnam V; Fleming KM; West J; Smith CJ; Jenkins RG; Fogarty A; Hubbard RB
    Thorax; 2011 Jun; 66(6):462-7. PubMed ID: 21525528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the coronavirus disease 2019 pandemic on hospital admissions for idiopathic pulmonary fibrosis: a nationwide population-based study.
    Cho IS; Lim J; Chang MS; Lee JH
    BMC Pulm Med; 2024 Aug; 24(1):430. PubMed ID: 39217306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data.
    Mortimer KM; Bartels DB; Hartmann N; Capapey J; Yang J; Gately R; Enger C
    Respiration; 2020; 99(2):108-118. PubMed ID: 31982886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry.
    Fan Y; Bender SD; Conoscenti CS; Davidson-Ray L; Cowper PA; Palmer SM; de Andrade JA;
    Chest; 2020 Jun; 157(6):1522-1530. PubMed ID: 32004554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older.
    Collard HR; Chen SY; Yeh WS; Li Q; Lee YC; Wang A; Raghu G
    Ann Am Thorac Soc; 2015 Jul; 12(7):981-7. PubMed ID: 25923447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing short-stay unplanned hospital admissions among children in England; time trends analysis '97-'06.
    Saxena S; Bottle A; Gilbert R; Sharland M
    PLoS One; 2009 Oct; 4(10):e7484. PubMed ID: 19829695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in hospital admissions for hypoglycaemia in England: a retrospective, observational study.
    Zaccardi F; Davies MJ; Dhalwani NN; Webb DR; Housley G; Shaw D; Hatton JW; Khunti K
    Lancet Diabetes Endocrinol; 2016 Aug; 4(8):677-685. PubMed ID: 27293218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidities and risk of mortality among hospitalized patients with idiopathic pulmonary fibrosis in Spain from 2002 to 2014.
    Pedraza-Serrano F; Jiménez-García R; López-de-Andrés A; Hernández-Barrera V; Esteban-Hernández J; Sánchez-Muñoz G; Puente-Maestu L; de-Miguel-Díez J
    Respir Med; 2018 May; 138():137-143. PubMed ID: 29724386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the recording of idiopathic pulmonary fibrosis in routinely collected electronic healthcare records in England.
    Morgan A; Gupta RS; George PM; Quint JK
    BMC Pulm Med; 2023 Jul; 23(1):256. PubMed ID: 37434192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study.
    Raimundo K; Chang E; Broder MS; Alexander K; Zazzali J; Swigris JJ
    BMC Pulm Med; 2016 Jan; 16():2. PubMed ID: 26732054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in England from 2008 to 2018: a cohort study.
    Gupta R; Morgan AD; George PM; Quint JK
    Thorax; 2024 Jun; 79(7):624-631. PubMed ID: 38688708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: a comparison of academic and non-academic programs.
    Alqalyoobi S; Fernández Pérez ER; Oldham JM
    BMC Pulm Med; 2020 Nov; 20(1):289. PubMed ID: 33160338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of National Trends in Admissions for Pulmonary Embolism.
    Smith SB; Geske JB; Kathuria P; Cuttica M; Schimmel DR; Courtney DM; Waterer GW; Wunderink RG
    Chest; 2016 Jul; 150(1):35-45. PubMed ID: 26905364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology, healthcare utilization, and related costs among patients with IPF: results from a German claims database analysis.
    Kreuter M; Picker N; Schwarzkopf L; Baumann S; Cerani A; Postema R; Maywald U; Dittmar A; Langley J; Patel H
    Respir Res; 2022 Mar; 23(1):62. PubMed ID: 35305632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of idiopathic pulmonary fibrosis in Korea based on the 2011 ATS/ERS/JRS/ALAT statement.
    Gjonbrataj J; Choi WI; Bahn YE; Rho BH; Lee JJ; Lee CW
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):742-6. PubMed ID: 25946370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis.
    Kaunisto J; Kelloniemi K; Sutinen E; Hodgson U; Piilonen A; Kaarteenaho R; Mäkitaro R; Purokivi M; Lappi-Blanco E; Saarelainen S; Kankaanranta H; Mursu A; Kanervisto M; Salomaa ER; Myllärniemi M
    BMC Pulm Med; 2015 Aug; 15():92. PubMed ID: 26285574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.